INTRODUCTION: Multimodal lifestyle interventions can delay or slow Alzheimer's disease (AD) in at-risk older adults, and plasma pTau217, a blood-based biomarker, now enables scalable AD risk stratification. Population-level screening integrating genetic, biomarker, and lifestyle risk factors, alongside attitudes toward...
M. Cochran, J. Pugh, T. Coleman et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.